Showing 161 - 180 results of 3,407 for search '"Amyloid beta"', query time: 0.94s Refine Results
  1. 161
  2. 162

    JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model. by Jihoon Jeong, Hyung Joon Park, Bo-Ram Mun, Ju Kyong Jang, Yong Moon Choi, Won-Seok Choi

    Published 2020-01-01
    “…The deposition of amyloid beta (Aβ) and tau hyperphosphorylation are hallmarks of AD and are major therapeutic targets. …”
    Get full text
    Article
  3. 163

    HHV-6A infection induces amyloid-beta expression and activation of microglial cells by Daria Bortolotti, Valentina Gentili, Antonella Rotola, Elisabetta Caselli, Roberta Rizzo

    Published 2019-12-01
    “…Abstract Background The control of viral infections in the brain involves the activation of microglial cells, the macrophages of the brain that are constantly surveying the central nervous system, and the production of amyloid-beta (Aβ) as an anti-microbial molecule. Recent findings suggest a possible implication of HHV-6A in AD. …”
    Get full text
    Article
  4. 164

    Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion by Joshua Raine, Nicholas Tolwinski, Jan Gruber, Ajay S. Mathuru

    Published 2024-06-01
    “…Abstract Background Recent reports suggest that amyloid beta (Aβ) peptides can exhibit prion-like pathogenic properties. …”
    Get full text
    Article
  5. 165
  6. 166

    C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta by Michael X. Hernandez, Pouya Namiranian, Eric Nguyen, Maria I. Fonseca, Andrea J. Tenner

    Published 2017-01-01
    “…Primary mouse neurons treated with both 100 nM C5a and 5 µM fibrillar amyloid beta (fAβ), to model what occurs in the AD brain, showed increased MAP-2 loss relative to either C5a or fAβ alone. …”
    Get full text
    Article
  7. 167

    Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target? by Castillo-Carranza DL, Guerrero-Muñoz MJ, Kayed R

    Published 2013-12-01
    “…Diana L Castillo-Carranza,1,2 Marcos J Guerrero-Muñoz,1,2 Rakez Kayed1–31Mitchell Center for Neurodegenerative Diseases, 2Departments of Neurology, Neuroscience, and Cell Biology, 3Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USAAbstract: Alzheimer's disease (AD) is characterized by the presence of amyloid plaques composed mainly of amyloid-β (Aβ) protein. Overproduction or slow clearance of Aβ initiates a cascade of pathologic events that may lead to formation of neurofibrillary tangles, neuronal cell death, and dementia. …”
    Get full text
    Article
  8. 168
  9. 169
  10. 170
  11. 171

    Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease by Mallory Gough, Catherine Parr-Sturgess, Edward Parkin

    Published 2011-01-01
    “…Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. …”
    Get full text
    Article
  12. 172
  13. 173
  14. 174
  15. 175

    Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model by Shun-Fat Lau, Wei Wu, Heukjin Seo, Amy K.Y. Fu, Nancy Y. Ip

    Published 2021-03-01
    “…Summary: Alzheimer’s disease is characterized by the deposition of extracellular amyloid-beta (Aβ) plaques. While microglial phagocytosis is a major mechanism through which Aβ is cleared, there is no method for quantitatively assessing Aβ phagocytic capacity of microglia in vivo. …”
    Get full text
    Article
  16. 176

    Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression by Caleigh A. Findley, Andrzej Bartke, Kevin N. Hascup, Erin R. Hascup

    Published 2019-06-01
    “…AD pathology hallmarks include accumulation of senile plaques and neurofibrillary tangles; however, evidence supports that soluble amyloid beta (Aβ), rather than insoluble plaques, may instigate synaptic failure. …”
    Get full text
    Article
  17. 177
  18. 178

    NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression. by Albert Tamburri, Anthony Dudilot, Sara Licea, Catherine Bourgeois, Jannic Boehm

    Published 2013-01-01
    “…There is considerable evidence supporting the involvement of oligomeric amyloid-beta (Aβ) in the etiology of Alzheimer's disease. …”
    Get full text
    Article
  19. 179
  20. 180